CLGN
Price
$1.38
Change
-$0.04 (-2.82%)
Updated
Jul 3 closing price
Capitalization
17.6M
45 days until earnings call
CVM
Price
$2.49
Change
-$0.03 (-1.19%)
Updated
Jul 3 closing price
Capitalization
12.79M
Interact to see
Advertisement

CLGN vs CVM

Header iconCLGN vs CVM Comparison
Open Charts CLGN vs CVMBanner chart's image
CollPlant Biotechnologies
Price$1.38
Change-$0.04 (-2.82%)
Volume$17.95K
Capitalization17.6M
Cel-Sci
Price$2.49
Change-$0.03 (-1.19%)
Volume$192.16K
Capitalization12.79M
CLGN vs CVM Comparison Chart in %
Loading...
CLGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CVM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CLGN vs. CVM commentary
Jul 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CLGN is a Buy and CVM is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 07, 2025
Stock price -- (CLGN: $1.38 vs. CVM: $2.49)
Brand notoriety: CLGN: Not notable vs. CVM: Notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CLGN: 13% vs. CVM: 76%
Market capitalization -- CLGN: $17.6M vs. CVM: $12.79M
CLGN [@Biotechnology] is valued at $17.6M. CVM’s [@Biotechnology] market capitalization is $12.79M. The market cap for tickers in the [@Biotechnology] industry ranges from $316.35B to $0. The average market capitalization across the [@Biotechnology] industry is $2.39B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CLGN’s FA Score shows that 1 FA rating(s) are green whileCVM’s FA Score has 0 green FA rating(s).

  • CLGN’s FA Score: 1 green, 4 red.
  • CVM’s FA Score: 0 green, 5 red.
According to our system of comparison, CLGN is a better buy in the long-term than CVM.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CLGN’s TA Score shows that 1 TA indicator(s) are bullish while CVM’s TA Score has 4 bullish TA indicator(s).

  • CLGN’s TA Score: 1 bullish, 7 bearish.
  • CVM’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, CVM is a better buy in the short-term than CLGN.

Price Growth

CLGN (@Biotechnology) experienced а +0.65% price change this week, while CVM (@Biotechnology) price change was +2.05% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.30%. For the same industry, the average monthly price growth was +17.40%, and the average quarterly price growth was -0.11%.

Reported Earning Dates

CLGN is expected to report earnings on Aug 21, 2025.

Industries' Descriptions

@Biotechnology (+6.30% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CLGN($17.6M) has a higher market cap than CVM($12.8M). CLGN YTD gains are higher at: -61.558 vs. CVM (-79.245). CLGN has higher annual earnings (EBITDA): -13.57M vs. CVM (-21.96M). CLGN has more cash in the bank: 10.7M vs. CVM (1.92M). CLGN has less debt than CVM: CLGN (2.84M) vs CVM (10.5M). CLGN has higher revenues than CVM: CLGN (2.47M) vs CVM (0).
CLGNCVMCLGN / CVM
Capitalization17.6M12.8M138%
EBITDA-13.57M-21.96M62%
Gain YTD-61.558-79.24578%
P/E RatioN/AN/A-
Revenue2.47M0-
Total Cash10.7M1.92M556%
Total Debt2.84M10.5M27%
FUNDAMENTALS RATINGS
CLGN vs CVM: Fundamental Ratings
CLGN
CVM
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
94
Overvalued
98
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
98100
PRICE GROWTH RATING
1..100
9666
P/E GROWTH RATING
1..100
257
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CLGN's Valuation (94) in the Biotechnology industry is in the same range as CVM (98). This means that CLGN’s stock grew similarly to CVM’s over the last 12 months.

CLGN's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as CVM (100). This means that CLGN’s stock grew similarly to CVM’s over the last 12 months.

CLGN's SMR Rating (98) in the Biotechnology industry is in the same range as CVM (100). This means that CLGN’s stock grew similarly to CVM’s over the last 12 months.

CVM's Price Growth Rating (66) in the Biotechnology industry is in the same range as CLGN (96). This means that CVM’s stock grew similarly to CLGN’s over the last 12 months.

CLGN's P/E Growth Rating (2) in the Biotechnology industry is somewhat better than the same rating for CVM (57). This means that CLGN’s stock grew somewhat faster than CVM’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CLGNCVM
RSI
ODDS (%)
Bearish Trend 5 days ago
86%
Bullish Trend 4 days ago
84%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
81%
Bearish Trend 4 days ago
90%
Momentum
ODDS (%)
Bearish Trend 4 days ago
80%
Bullish Trend 4 days ago
88%
MACD
ODDS (%)
Bearish Trend 4 days ago
86%
Bullish Trend 4 days ago
86%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
78%
Bullish Trend 4 days ago
82%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
87%
Bullish Trend 4 days ago
83%
Advances
ODDS (%)
N/A
Bullish Trend 5 days ago
80%
Declines
ODDS (%)
Bearish Trend 11 days ago
86%
Bearish Trend 7 days ago
90%
BollingerBands
ODDS (%)
N/A
N/A
Aroon
ODDS (%)
Bearish Trend 4 days ago
83%
Bearish Trend 4 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
CLGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CVM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MAXN3.850.17
+4.62%
Maxeon Solar Technologies Ltd
TMCI6.180.16
+2.66%
Treace Medical Concepts
STM32.290.59
+1.86%
STMicroelectronics NV
CUZ29.720.13
+0.44%
Cousins Properties
BOSC5.01-0.01
-0.20%
B.O.S. Better Online Solutions

CLGN and

Correlation & Price change

A.I.dvisor indicates that over the last year, CLGN has been loosely correlated with SPRO. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if CLGN jumps, then SPRO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CLGN
1D Price
Change %
CLGN100%
-2.54%
SPRO - CLGN
42%
Loosely correlated
+0.34%
CLLS - CLGN
33%
Poorly correlated
-4.24%
ASBP - CLGN
24%
Poorly correlated
+2.38%
CVM - CLGN
24%
Poorly correlated
-1.19%
ALZN - CLGN
24%
Poorly correlated
-2.00%
More

CVM and

Correlation & Price change

A.I.dvisor indicates that over the last year, CVM has been loosely correlated with NRXS. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if CVM jumps, then NRXS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CVM
1D Price
Change %
CVM100%
-1.19%
NRXS - CVM
59%
Loosely correlated
+7.05%
EYPT - CVM
37%
Loosely correlated
+0.62%
MGX - CVM
33%
Loosely correlated
+3.73%
ATHE - CVM
28%
Poorly correlated
+2.64%
EDIT - CVM
28%
Poorly correlated
+0.39%
More